NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Multi-Modal Cancer Therapies > Cancer Research UK to invest £11 million into cancer science in Oxford

Cancer Research UK to invest £11 million into cancer science in Oxford

24 January 2022 · Listed under Multi-Modal Cancer Therapies

Cancer Research UK has invested £11 million in the University of Oxford and Oxford-based NHS to accelerate the translation of its world-leading cancer research for patient benefit.

The Oxford Cancer Centre at the Churchill Hospital

The highly competitive Cancer Research UK Centre awards recognise the UK’s most innovative, high-impact cancer research and NHS-University collaborations. This coveted funding will see £11 million invested in Oxford and the Thames Valley’s cancer research and translational infrastructure, with a further £3 million for training over the next five years.

Cancer remains the second largest cause of global mortality, impacting the lives of millions worldwide. Half of us will be diagnosed with cancer, and there is a strong demand for investment in academic excellence, and to support partnerships with industry and public health organisations.

The funding for Oxford will draw together academics and experts from across its fundamental, translational and clinical research communities, including from cancer doctors, mathematicians, computer and data scientists, vaccinologists, immunologists, cellular biologists, drug discovery experts, clinical trialists, imaging experts and public health specialists.

Nationally and internationally, the new investment will foster a multisectoral approach and invest partnerships that will deliver short- and long-term patient benefit.

Professor Tim Elliott, co-Director of the Oxford Cancer network, says: “Nomination as a Centre of Excellence by CRUK is a strong endorsement of the quality and potential of the cancer research offered by Oxford clinicians and academics. Our researchers are working across divisions, departments and disciplines to deliver effective solutions to detecting and treating cancer.”

Professor Mark Middleton, co-Director of the Oxford Cancer network and Co-Lead of the Oxford BRC’s Cancer Theme, says: “This CRUK funding will knit together world-class research and clinical expertise to deliver earlier, better and safer treatments.

“Our Centre will support and grow local partnerships with NHS organisations, such as the Oxford University Hospitals NHS Foundation Trust, the Thames Valley Cancer Alliance and the Berkshire West, Oxfordshire and Buckinghamshire Clinical Commissioning Groups. It will strengthen relationships further afield, for example with the Centre in Scotland, with whom we look forward to working closely with in the coming years.”

Professor Sir John Bell, Regius Professor of Medicine at Oxford University, said: “CRUK remains the key funder for cancer research and its support will help Oxford deliver an integrated programme bringing together healthcare providers, basic and clinical research scientists and industry. The support from CRUK is crucial for us to deliver this agenda and will in the end create opportunities for us to develop new therapies and diagnostics in cancer.”

The £11 million award for the CRUK Oxford Centre is overseen by Oxford Cancer, the University’s cancer research network. Money will be invested in Oxford’s key themes:

  • Cancer early detection – striving to achieve NHS England’s Long-Term Plan target to detect 75% cancers at an early stage by 2028.
  • Cancer big data– using the data science expertise in Oxford by analysing large, complex data sets, to detect cancer earlier and treat it better.
  • Developments in immuno-oncology– building on existing immunology successes in Oxford, such as the COVID-19 vaccine, and applying these novel technologies to realise the long-term, curative benefits of immunotherapy.
  • Novel therapeutics and diagnostics- developing new therapies and methods that precisely target treatments more effectively, as well as improving the use of existing ones.

An additional £3 million in funding is dedicated specifically to studentships, to help train the next generation of cancer researchers and allow them pursue new and ambitious ideas.

← New multi-cancer early detection blood test study opens
Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre